GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Ultralife Corp (NAS:ULBI) » Definitions » EBIT

Ultralife (Ultralife) EBIT : $15.3 Mil (TTM As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Ultralife EBIT?

Ultralife's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $4.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $15.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ultralife's annualized ROC % for the quarter that ended in Mar. 2024 was 8.71%. Ultralife's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 20.27%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ultralife's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.45%.


Ultralife EBIT Historical Data

The historical data trend for Ultralife's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultralife EBIT Chart

Ultralife Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.31 7.46 0.09 0.51 11.13

Ultralife Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 5.16 2.34 3.68 4.13

Competitive Comparison of Ultralife's EBIT

For the Electrical Equipment & Parts subindustry, Ultralife's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ultralife's EV-to-EBIT Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Ultralife's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ultralife's EV-to-EBIT falls into.



Ultralife EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ultralife  (NAS:ULBI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ultralife's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=16.252 * ( 1 - 19.49% )/( (149.465 + 151.089)/ 2 )
=13.0844852/150.277
=8.71 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Ultralife's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=16.508/( ( (21.117 + max(58.277, 0)) + (20.67 + max(62.827, 0)) )/ 2 )
=16.508/( ( 79.394 + 83.497 )/ 2 )
=16.508/81.4455
=20.27 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(31.761 + 42.215 + 6.031) - (18.615 + 0 + 3.115)
=58.277

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(35.278 + 43.821 + 5.104) - (19.363 + 0 + 2.013)
=62.827

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ultralife's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=15.304/205.395
=7.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ultralife EBIT Related Terms

Thank you for viewing the detailed overview of Ultralife's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ultralife (Ultralife) Business Description

Traded in Other Exchanges
Address
2000 Technology Parkway, Newark, NY, USA, 14513
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company design, manufacture, install and maintain power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from Battery and Energy Products segment.
Executives
Bradford T Whitmore 10 percent owner 5215 OLD ORCHARD ROAD, SUITE 620, SKOKIE IL 60077
Michael Edward Manna director, officer: President and CEO 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
W. Shaw Robert director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Janie Goddard director C/O ACON - 1133 CONNECTICUT AVENUE, NW, SUITE 700, WASHINGTON DC 20036
Thomas Louis Saeli director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Philip A Fain officer: Vice President C/O CXO ON THE GO OF DELAWARE, LLC, 3349 MONROE AVENUE, # 256, ROCHESTER NY 14618
Michael D Popielec director, officer: President and CEO 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Steven Mark Anderson director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Sunray I, Llc 10 percent owner 1560 SHERMAN AVENUE, SUITE 900, EVANSTON IL 60201
James A. Croce director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Spurgeon Corp 10 percent owner 407 S. THIRD STREET, SUITE 230, GENEVA IL 60134
Patricia C Barron director 6601 WEST BROAD STREET, P O BOX 27003, RICHMOND VA 23261-7003
Daniel W Christman director C/O ENTEGRIS, INC., 129 CONCORD ROAD, BILLERICA MA 01821
Paula H Cholmondeley director 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Ranjit C Singh director

Ultralife (Ultralife) Headlines